Physician profile

Michael V Orlov

Cardiovascular Disease · Brighton, MA

NPI 1407844020

$23,878.69

in general payments reported to CMS, 2019-2025

26 companies · $1,840 in 2025

The $1,840 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$6,300.00
Food and Beverage$2,627.81
Travel and Lodging$978.37

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $13,943.69 2019-2025 Ensite, Assurity, Ensite Precision
Medtronic, INC. $7,106.20 2022-2025 Advisa Dr Mri Surescan, Selectsecure, Cobalt Dr Mri Surescan
Biotronik INC. $1,055.13 2019-2025
Boston Scientific Corporation $444.34 2019-2025 Ekosonic, Watchman Flx, Watchman Access System
Medtronic Vascular, INC. $149.14 2019
Impulse Dynamics (USA) INC. $139.95 2022
Philips North America LLC $131.81 2019
E.R. Squibb & Sons, L.L.C. $120.47 2020-2025 Camzyos
Janssen Pharmaceuticals, INC $118.37 2019
Edwards Lifesciences Corporation $93.99 2024-2025
Atricure, INC. $79.27 2023
Novartis Pharmaceuticals Corporation $61.06 2024-2025
Cardiva Medical, INC. $57.81 2025 Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f
Elutia, INC. $50.09 2021
Boehringer Ingelheim Pharmaceuticals, INC. $49.35 2019-2025 Jardiance
Show all 26 companies
CompanyGeneral paymentsYearsTop products
Scpharmaceuticals INC. $44.93 2024-2025
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $34.50 2019-2025 Lifevest
Heartflow, INC. $25.95 2025
Bayer Healthcare Pharmaceuticals INC. $25.79 2025
Amgen INC. $25.15 2025 Repatha
Astrazeneca Pharmaceuticals LP $22.30 2019
Pfizer INC. $22.11 2025
Esperion Therapeutics, INC. $19.83 2024 Nexletol
Alnylam Pharmaceuticals INC. $19.42 2024 Onpattro
Merck Sharp & Dohme LLC $19.20 2024 Verquvo
Amarin Pharma, INC. $18.84 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael V Orlov

$23,878.69

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $1,840 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/18764/michael-v-orlov

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.